BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Hepatitis C virus
1
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
4/4/2018 1:15:45 PM | Browse: 65 | Download: 12
2
Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
3/26/2018 8:48:04 AM | Browse: 61 | Download: 28
3
Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release
3/26/2018 8:48:04 AM | Browse: 39 | Download: 9
4
Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions
3/16/2018 12:27:25 PM | Browse: 62 | Download: 12
5
Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents
3/4/2018 12:36:47 PM | Browse: 43 | Download: 15
6
Hepatitis C virus: Morphogenesis, infection and therapy
3/4/2018 12:36:47 PM | Browse: 51 | Download: 15
7
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016
1/26/2018 8:09:36 AM | Browse: 89 | Download: 31
8
Role of inflammatory response in liver diseases: Therapeutic strategies
1/26/2018 8:09:36 AM | Browse: 78 | Download: 22
9
Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
1/19/2018 9:46:49 AM | Browse: 106 | Download: 29
10
Hepatitis C virus core protein-induced miR-93-5p inhibits IFN signaling pathway through targeting IFNAR1
1/14/2018 5:07:58 AM | Browse: 83 | Download: 69
11
Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas
1/7/2018 4:21:05 AM | Browse: 92 | Download: 30
12
Estrogen, estrogen receptors, and hepatocellular carcinoma: are we there yet?
1/7/2018 4:21:04 AM | Browse: 86 | Download: 27
13
Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
12/27/2017 10:31:19 AM | Browse: 99 | Download: 34
14
Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
12/12/2017 8:34:13 AM | Browse: 92 | Download: 34
15
Global elimination of hepatitis C virus infection: Progresses and the remaining challenges
11/24/2017 12:22:15 AM | Browse: 138 | Download: 42
16
Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
8/28/2017 6:54:48 AM | Browse: 160 | Download: 221
17
(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes
8/28/2017 6:54:48 AM | Browse: 128 | Download: 167
18
Lurking epidemic of hepatitis C virus infection in Iran: A call to action
8/25/2017 1:53:29 AM | Browse: 120 | Download: 115
19
Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
8/19/2017 11:33:53 AM | Browse: 87 | Download: 130
20
Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model
7/28/2017 8:16:18 AM | Browse: 109 | Download: 589
21
Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study
7/17/2017 11:13:33 PM | Browse: 103 | Download: 161
22
Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease
7/5/2017 4:40:07 AM | Browse: 131 | Download: 265
23
Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
6/7/2017 7:22:42 AM | Browse: 411 | Download: 1182
24
Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients
5/12/2017 10:16:48 PM | Browse: 164 | Download: 423
25
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection
4/13/2017 3:45:15 PM | Browse: 167 | Download: 299
26
Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients
4/13/2017 3:45:15 PM | Browse: 186 | Download: 222
27
Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
3/24/2017 9:18:00 AM | Browse: 277 | Download: 536
28
Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data
3/13/2017 7:05:00 PM | Browse: 247 | Download: 322
29
Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C
3/13/2017 1:20:00 PM | Browse: 208 | Download: 468
30
Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review
3/6/2017 1:27:00 PM | Browse: 281 | Download: 358
31
Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease
2/26/2017 6:20:00 PM | Browse: 257 | Download: 697
32
Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment
2/26/2017 6:20:00 PM | Browse: 202 | Download: 289
33
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
2/17/2017 8:32:00 AM | Browse: 213 | Download: 203
34
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection
2/6/2017 9:08:00 AM | Browse: 186 | Download: 356
35
Hepatitis C virus-associated pruritus: Etiopathogenesis and therapeutic strategies
1/22/2017 11:39:00 AM | Browse: 212 | Download: 510
36
PI3K/SHIP2/PTEN pathway in cell polarity and hepatitis C virus pathogenesis
1/6/2017 8:51:00 AM | Browse: 428 | Download: 915
37
<i>PNPLA3</i> polymorphism increases risk for and severity of chronic hepatitis C liver disease
12/15/2016 4:06:00 PM | Browse: 386 | Download: 429
38
Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C
12/6/2016 5:24:00 PM | Browse: 142 | Download: 261
39
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
11/26/2016 6:56:00 PM | Browse: 212 | Download: 349
40
New real-time-PCR method to identify single point mutations in hepatitis C virus
11/18/2016 3:13:00 PM | Browse: 221 | Download: 1165
41
Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
11/18/2016 3:13:00 PM | Browse: 204 | Download: 466
42
Hepatitis C infection and renal cell carcinoma: A systematic review and meta-analysis
11/13/2016 5:46:00 PM | Browse: 207 | Download: 400
43
Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection
11/12/2016 1:33:00 PM | Browse: 214 | Download: 692
44
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections
11/4/2016 10:35:00 AM | Browse: 206 | Download: 305
45
Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention
10/25/2016 8:46:00 AM | Browse: 386 | Download: 572
46
Regulatory and activated effector T cells in chronic hepatitis C virus: Relation to autoimmunity
10/25/2016 8:46:00 AM | Browse: 196 | Download: 665
47
Retrospective study of the associations between hepatitis C virus infection and metabolic factors
10/25/2016 8:46:00 AM | Browse: 310 | Download: 308
48
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
10/12/2016 2:18:00 PM | Browse: 194 | Download: 229
49
Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014
9/26/2016 8:04:00 AM | Browse: 259 | Download: 588
50
Predictive potential of <i>IL-28B</i> genetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective
9/14/2016 11:03:00 AM | Browse: 229 | Download: 580